Melanotan 2
Tan + libido.
- Sizes available
- 10mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Tanning and libido (research compound, not approved).
Mechanism · Synthetic α-MSH analog. MC1R + MC4R agonist (tan + libido side-effects).
Best for. Not for.
Best for
- Dual tan and libido effect for research use only
- Cost-sensitive. Cheaper than Vyleesi or Scenesse
- Users who can tolerate a slow ramp (nausea can be strong)
Not for
- Anyone requiring FDA approval (no FDA or EMA approval, warning letters issued)
- People with many moles or atypical nevi (multiple reports of discoloration and new moles)
- Skin cancer / family history
- Cardiovascular instability. Transient BP changes
Mechanism, dose, ramp, risk.
- Mechanism
- MC1R/MC4R agonist. Tanning + libido side effect.Source · PEPVERA editorial
- Target dose
- 0.5 mg / day loading, then 0.5 mg 2x/wk maintenance.Source · PEPVERA editorial
- Ramp
- Slow ramp to avoid nausea.Source · PEPVERA editorial
- Risks
- Moles darken, nausea.Source · PEPVERA editorial
Compared to its siblings.
Melanotan 2
Tanning and libido (research compound, not approved).
Pros
- · Lower cost than Scenesse (~$25k per implant) and easier to procure.
- · Includes libido side-effect via MC4R, absent in MT-1.
Cons
- · No FDA approval, unlike MT-1 Scenesse (2019 EPP).
- · Stronger nausea and mole discoloration than MT-1.
- · No FDA approval and mole discoloration risk, versus PT-141 Vyleesi.
Melanotan 1 (Afamelanotide)
Selective MC1R agonist (Scenesse). Tan only, FDA and EMA approved.
Pros
- · FDA 2019 EPP indication
- · Less nausea
- · Preferred when no libido side effect is desired
Cons
- · Higher cost (Scenesse runs about $25k per implant)
- · Procurement difficulty
See Melanotan 1 (Afamelanotide) →
PT-141 (Bremelanotide)
MC4R-selective libido. FDA Vyleesi 2019 with almost no tan side effect.
Pros
- · FDA approval
- · No mole discoloration
Cons
- · No tan effect
See PT-141 (Bremelanotide) →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 4 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| NG PeptidesUS | $24.99$2.50/mg · 10mg | Sample COA published | 3 days | Out of stock |
| SwissChemsUS | $34.95$3.50/mg · 10mg | COA with shipment | 3 days | |
| Ascension PeptidesUS | $40$4.00/mg · 10mg | Sample COA published | 3 days | |
| Ameano PeptidesUS | $44$4.40/mg · 10mg | Sample COA published | 2 days |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Moles darken, nausea. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
Slow ramp to avoid nausea.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1–2
0.5 mg / day loading, then 0.5 mg 2x/wk maintenance.
Initiation
Week 3–4
0.5 mg / day loading, then 0.5 mg 2x/wk maintenance.
Signal emerges
Week 5–8
0.5 mg / day loading, then 0.5 mg 2x/wk maintenance.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.
drive · II · SwissChems
Melanotan 2 · 10mg